BAUDAX BIO INC's ticker is and the CUSIP is 07160F206. A total of 23 filers reported holding BAUDAX BIO INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $19,000 | – | 23,323 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 47,117 | $40,000 | 0.03% |
| Warberg Asset Management LLC | 34,500 | $29,000 | 0.01% |
| Walleye Capital LLC | 195,095 | $165,000 | 0.01% |
| Alyeska Investment Group, L.P. | 460,000 | $389,000 | 0.00% |
| Ikarian Capital, LLC | 2,966 | $3,000 | 0.00% |
| Virtu Financial LLC | 20,504 | $17,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 45 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| UBS Group AG | 7,135 | $6,000 | 0.00% |
| CITIGROUP INC | 30 | $0 | 0.00% |